Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 20;8(10):5195-5205.
doi: 10.1002/fsn3.1835. eCollection 2020 Oct.

Therapeutic and nutraceutical potentials of a brown seaweed Sargassum fusiforme

Jian Liu  1   2 , Sibusiso Luthuli  1 , Yue Yang  1 , Yang Cheng  1 , Ya Zhang  1 , Mingjiang Wu  1 , Jong-Il Choi  2 , Haibin Tong  1
Affiliations
Review

Therapeutic and nutraceutical potentials of a brown seaweed Sargassum fusiforme

Jian Liu et al. Food Sci Nutr. .

Abstract

Sargassum fusiforme, also known as Yangqicai () in Chinese and Hijiki in Japanese, is a brown seaweed that grows abundantly along the rocky coastlines of Asian countries such as Japan, Korea, and China. The first use of S. fusiforme as a traditional Chinese medicinal plant was recorded in the Shennong Bencao Jing, dated 200 AD. It was referred to as Haizao (seaweed), renowned for treating Yinglu (tumor-like induration), dysuria, and edema. Currently, it is commonly used in traditional cuisine as it is rich in dietary fiber and minerals such as calcium, iron, and magnesium. Owing to its health benefits, S. fusiforme remains popular in China, Korea, and Japan, as well as in the UK and in North America. Currently, there is a lack of research on S. fusiforme; thus, we review the therapeutic effects of S. fusiforme, such as anticancer, antiangiogenic, and antiviral effects, in vitro and in vivo as reported during the past two decades. This review may promote further research on the therapeutic uses of S. fusiforme. Furthermore, we discuss the processes and considerations involved in using drugs produced from marine sources.

Keywords: Sargassum fusiforme; antiangiogenic; antitumor; immunomodulatory; neurodegenerative.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allen, K. D. , & Golightly, Y. M. (2015). Epidemiology of osteoarthritis: State of the evidence. Current Opinion in Rheumatology, 27, 276–283. 10.1097/BOR.0000000000000161 - DOI - PMC - PubMed
    1. Anderson, N. S. , Campbell, J. W. , Harding, M. M. , Rees, D. A. , & Samuel, J. W. B. (1969). X‐ray diffraction studies of polysaccharide sulphates: Double helix models for κ‐ and ι‐carrageenans. Journal of Molecular Biology, 45, 85–97. 10.1016/0022-2836(69)90211-3 - DOI - PubMed
    1. Barve, R. A. , Minnerly, J. C. , Weiss, D. J. , Meyer, D. M. , Aguiar, D. J. , Sullivan, P. M. , … Head, R. D. (2007). Transcriptional profiling and pathway analysis of monosodium iodoacetate‐induced experimental osteoarthritis in rats: Relevance to human disease. Osteoarthritis and Cartilage, 15, 1190–1198. 10.1016/j.joca.2007.03.014 - DOI - PubMed
    1. Bathina, S. , & Das, U. N. (2015). Brain‐derived neurotrophic factor and its clinical implications. Archives of Medical Science – AMS, 11, 1164–1178. 10.5114/aoms.2015.56342 - DOI - PMC - PubMed
    1. Bauer, J. H. , & Helfand, S. L. (2006). New tricks of an old molecule: Lifespan regulation by p53. Aging Cell, 5, 437–440. 10.1111/j.1474-9726.2006.00228.x - DOI - PMC - PubMed

LinkOut - more resources